Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, August 11, 2023
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
Mayank Mamtani Maintained (ALT) at Strong Buy with Decreased Target to $15 on, Aug 11th, 2023
Mayank Mamtani of B. Riley Securities, Maintained "Altimmune, Inc." (ALT) at Strong Buy with Decreased Target from $20 to $15 on, Aug 11th, 2023.
Mayank has made no other calls on ALT in the last 4 months.
There are 2 other peers that have a rating on ALT. Out of the 2 peers that are also analyzing ALT, 0 agree with Mayank's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Mayank
- Jonathan Wolleben of "JMP Securities" Reiterated at Buy and Held Target at $15 on, Wednesday, July 12th, 2023
- Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $50 on, Monday, May 15th, 2023
